Kowal Investment Group’s Phibro Animal Health PAHC Stock Holding History

Kowal Investment Group’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1	Closed	–	–	684
2021 Q3	$0	Buy	+1	New	+$24	﹤0.01%	985

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kowal Investment Group's PAHC Position: Q4 2021 in Review

Kowal Investment Group sold out of Phibro Animal Health (PAHC) in Q4 2021, closing a stake of 1 share.

Kowal Investment Group first reported a position in PAHC in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 145 funds tracked by Wall St. Rank hold PAHC as of Q4 2021.

Kowal Investment Group reported no remaining Phibro Animal Health position as of Q4 2021 after selling out during the quarter.
Kowal Investment Group sold 1 Phibro Animal Health share in Q4 2021.
Kowal Investment Group first reported a position in Phibro Animal Health in Q3 2021 and held it in 1 quarter.
Kowal Investment Group's Phibro Animal Health position peaked at $0 in Q3 2021.
145 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2021.

Based on Kowal Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.